搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
排序方式
最佳匹配
最新鲜
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
资讯
6 天
FDA取消自体CAR-T细胞免疫疗法风险评估与缓解策略(REMS)
2025年6月27日美国食品药品监督管理局 (FDA)宣布,取消当前已获批的BCMA及CD19靶向自体嵌合抗原受体 (CAR)T细胞免疫疗法的风险评估与缓解策略 (risk evaluation and mitigation strategy,REMS)要求。FDA认定无需REMS即可确保此类免疫疗法的安全性与有效性。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Central Texas flash floods
Suffers serious injuries
Death ruled a homicide
Ex-doctor refuses to answer
Makes first visit to Asia
Greece blocks asylum claims
Sinner defeats Shelton
Hiker dies in Grand Canyon
Utah judge sets execution
US sanctions UN official
Tunnel collapses in LA
Cracker sandwiches recalled
Barbie with Type 1 diabetes
Loan interest to restart
Former Gov. DiPrete dies
Trump admin sues California
Six firefighters injured
Sentenced to 8+ years
Bitcoin hits record high
Six agents suspended
Russian strikes on Kyiv
Los Angeles joins ACLU suit
Ex-Jazz coach, GM dies
Cases hit highest level
To release web browser
Cyclist LeMond honored
Harvard faces subpoenas
Copper tariffs to start Aug 1
X CEO resigns
5-yr extension w/ Thunder
Booker gets max extension
Interim NASA administrator
Confirmed to lead FAA
14th Wimbledon semifinal
Malaysia’s ex-PM turns 100
反馈